154 related articles for article (PubMed ID: 1828136)
1. Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in mice.
Ji B; Perani EG; Grosset JH
Antimicrob Agents Chemother; 1991 Mar; 35(3):579-81. PubMed ID: 1828136
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice.
Ji B; Perani EG; Petinom C; Grosset JH
Antimicrob Agents Chemother; 1996 Feb; 40(2):393-9. PubMed ID: 8834886
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice.
Ji B; Perani EG; Petinon C; Grosset JH
Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):556-61. PubMed ID: 1338596
[TBL] [Abstract][Full Text] [Related]
4. Further study of the effectiveness of single doses of clarithromycin and minocycline against Mycobacterium leprae in mice.
Xiong JH; Ji B; Perani EG; Pétinon C; Grosset JH
Int J Lepr Other Mycobact Dis; 1994 Mar; 62(1):37-42. PubMed ID: 8189087
[TBL] [Abstract][Full Text] [Related]
5. Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy.
Lenz SM; Collins JH; Ray NA; Hagge DA; Lahiri R; Adams LB
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008583. PubMed ID: 32936818
[TBL] [Abstract][Full Text] [Related]
6. Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy.
Ji B; Jamet P; Perani EG; Bobin P; Grosset JH
J Infect Dis; 1993 Jul; 168(1):188-90. PubMed ID: 8257487
[TBL] [Abstract][Full Text] [Related]
7. Activity of combinations of dapsone, rifampin, minocycline, clarithromycin, and sparfloxacin against M. leprae-infected mice.
Gelber RH; Siu P; Tsang M; Richard V; Chehl SK; Murray LP
Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):259-64. PubMed ID: 7602221
[TBL] [Abstract][Full Text] [Related]
8. Combination of rifapentine-moxifloxacin-minocycline (PMM) for the treatment of leprosy.
Ji B; Grosset J
Lepr Rev; 2000 Dec; 71 Suppl():S81-7. PubMed ID: 11201894
[TBL] [Abstract][Full Text] [Related]
9. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
Walker LL; Van Landingham RM; Shinnick TM
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal activity of a single-dose combination of ofloxacin plus minocycline, with or without rifampin, against Mycobacterium leprae in mice and in lepromatous patients.
Ji B; Sow S; Perani E; Lienhardt C; Diderot V; Grosset J
Antimicrob Agents Chemother; 1998 May; 42(5):1115-20. PubMed ID: 9593137
[TBL] [Abstract][Full Text] [Related]
11. Bactericidal activity of single dose of clarithromycin plus minocycline, with or without ofloxacin, against Mycobacterium leprae in patients.
Ji B; Jamet P; Perani EG; Sow S; Lienhardt C; Petinon C; Grosset JH
Antimicrob Agents Chemother; 1996 Sep; 40(9):2137-41. PubMed ID: 8878595
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of anti-bacterial activity of Rifapentine, Clarithromycin, Minocycline, Moxifloxacin, Ofloxacin and their combinations in Murine Model of Rifampicin Resistant Leprosy.
Joseph P; Ponnaiya J; Das M; Chaitanya VS; Arumugam S; Ebenezer M
Indian J Lepr; 2016; 88(3):147-58. PubMed ID: 30207440
[TBL] [Abstract][Full Text] [Related]
13. Bactericidal activities of HMR 3647, moxifloxacin, and rifapentine against Mycobacterium leprae in mice.
Consigny S; Bentoucha A; Bonnafous P; Grosset J; Ji B
Antimicrob Agents Chemother; 2000 Oct; 44(10):2919-21. PubMed ID: 10991891
[TBL] [Abstract][Full Text] [Related]
14. Activities of various macrolide antibiotics against Mycobacterium leprae infection in mice.
Gelber RH; Siu P; Tsang M; Murray LP
Antimicrob Agents Chemother; 1991 Apr; 35(4):760-3. PubMed ID: 1648889
[TBL] [Abstract][Full Text] [Related]
15. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
Ganapati R; Revankar CR; Pai VV; Kingsley S
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413
[No Abstract] [Full Text] [Related]
16. Single-dose treatment for paucibacillary leprosy; field implications.
Revankar CR; Pai VV; Samy MS; Ganapati R
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):312-4. PubMed ID: 10575415
[No Abstract] [Full Text] [Related]
17. Single-dose treatment for paucibacillary leprosy; clinical problems and management.
Pai VV; Bulchand HO; Revankar CR; Ganapati R
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414
[No Abstract] [Full Text] [Related]
18. Single dose multidrug therapy for single lesion paucibacillry leprosy.
Salafia A
Indian J Lepr; 1998; 70(2):216-9; author reply 219-21. PubMed ID: 9724861
[No Abstract] [Full Text] [Related]
19. Activity of minocycline in Mycobacterium leprae-infected mice.
Gelber RH
J Infect Dis; 1987 Jul; 156(1):236-9. PubMed ID: 3298454
[No Abstract] [Full Text] [Related]
20. Further studies of the killing of M. leprae by aminoglycosides: reduced dosage and frequency of administration.
Gelber RH
Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):78-82. PubMed ID: 3549941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]